Comprehensive Assessment of HIV Target Cells in the Distal Human Gut Suggests Increasing HIV Susceptibility Toward the Anus
暂无分享,去创建一个
G. Steinbach | K. Smythe | M. Curlin | J. Lord | S. Hughes | F. Hladik | J. Randolph-Habecker | McElrath Mj | K. Melton | Matthias Mack | Alicia Sato | George A. Diaz | Richard M. Novak | Janine Maenza | Ann Duerr | Nicole Frahm | Tracy Goodpaster
[1] R. Kaul,et al. Quality and quantity: mucosal CD4+ T cells and HIV susceptibility. , 2012, Current opinion in HIV and AIDS.
[2] B. Caffo,et al. Distribution of Cell-Free and Cell-Associated HIV Surrogates in the Colon After Simulated Receptive Anal Intercourse in Men Who Have Sex With Men , 2012, Journal of acquired immune deficiency syndromes.
[3] Myron S. Cohen,et al. Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission , 2011, Science Translational Medicine.
[4] J Christopher Love,et al. A high-throughput single-cell analysis of human CD8⁺ T cell functions reveals discordance for cytokine secretion and cytolysis. , 2011, The Journal of clinical investigation.
[5] C. Herrera,et al. Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants , 2011, AIDS.
[6] A. Carballo-Diéguez,et al. First Phase 1 Double-Blind, Placebo-Controlled, Randomized Rectal Microbicide Trial Using UC781 Gel with a Novel Index of Ex Vivo Efficacy , 2011, PloS one.
[7] C. Bain,et al. Mucosal Macrophages in Intestinal Homeostasis and Inflammation , 2011, Journal of Innate Immunity.
[8] R. Cheynier,et al. Rapid Dissemination of SIV Follows Multisite Entry after Rectal Inoculation , 2011, PloS one.
[9] Erin F. Simonds,et al. Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum , 2011, Science.
[10] J. Kappes,et al. Stromal Down-Regulation of Macrophage CD4/CCR5 Expression and NF-κB Activation Mediates HIV-1 Non-Permissiveness in Intestinal Macrophages , 2011, PLoS pathogens.
[11] D. Artis,et al. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. , 2011, Immunity.
[12] Marie-Claude Boily,et al. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention , 2010, International journal of epidemiology.
[13] L. Novak,et al. Dendritic cells transmit HIV‐1 through human small intestinal mucosa , 2010, Journal of leukocyte biology.
[14] Douglas J. Taylor,et al. Heterosexual Anal Intercourse Has the Potential to Cause a Significant Loss of Power in Vaginal Microbicide Effectiveness Studies , 2010, Sexually transmitted diseases.
[15] Yunda Huang,et al. In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide , 2010, PloS one.
[16] R. Kaul,et al. The integrin α4β7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1 , 2009, Proceedings of the National Academy of Sciences.
[17] R. Baggaley,et al. The role of heterosexual anal intercourse for HIV transmission in developing countries: are we ready to draw conclusions? , 2009, Sexually Transmitted Infections.
[18] J. Ritz,et al. Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[19] J. Zack,et al. CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function. , 2009, Virology.
[20] H. Richter,et al. Macrophages in Vaginal but Not Intestinal Mucosa Are Monocyte-Like and Permissive to Human Immunodeficiency Virus Type 1 Infection , 2009, Journal of Virology.
[21] E. Fuchs,et al. Topical microbicides to prevent HIV: clinical drug development challenges. , 2009, Annual review of pharmacology and toxicology.
[22] Donald K Carter,et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis , 2008, The Lancet.
[23] Devan V Mehrotra,et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial , 2008, The Lancet.
[24] J. Heeney,et al. Prevention of SIV Rectal Transmission and Priming of T Cell Responses in Macaques after Local Pre-exposure Application of Tenofovir Gel , 2008, PLoS medicine.
[25] M. McElrath,et al. Setting the stage: host invasion by HIV , 2008, Nature Reviews Immunology.
[26] A. Carballo-Diéguez,et al. Women's anal sex practices: implications for formulation and promotion of a rectal microbicide. , 2008, AIDS education and prevention : official publication of the International Society for AIDS Education.
[27] W. Boscardin,et al. Characterization of Baseline Intestinal Mucosal Indices of Injury and Inflammation in Men for Use in Rectal Microbicide Trials (HIV Prevention Trials Network-056) , 2007, Journal of acquired immune deficiency syndromes.
[28] J. Grivel,et al. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1 , 2007, AIDS.
[29] M. Markowitz,et al. Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acuteand Early Human Immunodeficiency Virus Type 1 Infection , 2006, Journal of Virology.
[30] C. Serhan,et al. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression , 2006, Nature Immunology.
[31] C. Morris,et al. Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, Kenya , 2006, Sexually Transmitted Infections.
[32] J. Grivel,et al. Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides , 2006, AIDS.
[33] Jeannette Guarner,et al. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. , 2005, The Journal of infectious diseases.
[34] Richard A Fekete,et al. Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] E. Soilleux,et al. Binding and Transfer of Human Immunodeficiency Virus by DC-SIGN+ Cells in Human Rectal Mucosa , 2005, Journal of Virology.
[36] Qingsheng Li,et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells , 2005, Nature.
[37] Mario Roederer,et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.
[38] D. Price,et al. CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.
[39] Christine Hogan,et al. Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.
[40] J. Flamm,et al. Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.
[41] G. Shaw,et al. Macrophage HIV‐1 infection and the gastrointestinal tract reservoir , 2003, Journal of leukocyte biology.
[42] J. Kappes,et al. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells , 2002, Nature Medicine.
[43] I. Chen,et al. A Preponderance of CCR5+CXCR4+ Mononuclear Cells Enhances Gastrointestinal Mucosal Susceptibility to Human Immunodeficiency Virus Type 1 Infection , 2001, Journal of Virology.
[44] G. Shaw,et al. Biological parameters of HIV‐1 infection in primary intestinal lymphocytes and macrophages , 2000, Journal of leukocyte biology.
[45] G. Shaw,et al. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa. , 2000, The Journal of infectious diseases.
[46] C. Mackay,et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue , 2000, AIDS.
[47] K. Mayer,et al. Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team. , 2000, Journal of acquired immune deficiency syndromes.
[48] H. Brühl,et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.
[49] C. Elia,et al. Expression of lymphocyte-endothelial receptor-ligand pairs, α4β7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease , 1999, Gut.
[50] G. Shaw,et al. Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5. , 1999, Gastroenterology.
[51] S. Dandekar,et al. Gastrointestinal T Lymphocytes Retain High Potential for Cytokine Responses but Have Severe CD4+ T-Cell Depletion at All Stages of Simian Immunodeficiency Virus Infection Compared to Peripheral Lymphocytes , 1998, Journal of Virology.
[52] D. Ho,et al. In Vivo Distribution of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5 , 1998, Journal of Virology.
[53] R P Johnson,et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. , 1998, Science.
[54] P. D. Smith,et al. Intestinal macrophages and response to microbial encroachment , 2011, Mucosal Immunology.
[55] Xiaoxu Han,et al. Expression of chemokine receptors on natural killer cells in HIV-infected individuals. , 2008, Cellular immunology.